Startup managers often find themselves interacting in parallel with multiple technology transfer officers. Organizing these collaborations is easier said than done, so we asked four leading authorities how to go about it to enhance the chances of turning a licensed invention into a commercial success.
Good relationships between inventors and technology transfer officers can reap dividends at every stage in the marketing of an invention or in forming a company. Conversely, a lack of communication can play into the hands of investors.
Biotech startups hoping that the US Supreme Court will resolve the closely watched Merck v. Integra case, once and for all, could be in for still more waiting and uncertainty.
With commercialization of academic research slowly rising, debate is brewing over whether spinning off young companies can become too much of a good thing.
Without a strategy to guide the development of their IP portfolios, companies may waste valuable resources and miss opportunities to protect valuable inventions.
University licensing is likely to increase as pharma looks to supplement drug pipelines, and venture capitalists broaden their focus to platform technologies.
